| Christine Cashman, MS, CCC-SLP | |
|
Mill Brook School, 53 South Curtisville Rd, Concord, NH 03301 | |
| (603) 225-0830 | |
| Not Available |
| Full Name | Christine Cashman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | Mill Brook School, Concord, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437822806 | NPI | - | NPPES |
| 3073388 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1280 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christine Cashman, MS, CCC-SLP Mill Brook School, 53 South Curtisville Rd, Concord, NH 03301 Ph: (603) 225-0830 | Christine Cashman, MS, CCC-SLP Mill Brook School, 53 South Curtisville Rd, Concord, NH 03301 Ph: (603) 225-0830 |
News Archive
ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced it has received CE Mark approval to distribute the ATS 3f Enable® Aortic Bioprosthesis in the European Union, indicating it is compliant with relevant European health, safety, and environmental protection legislation.
The link between obesity and cardiovascular diseases is well acknowledged. Being obese or overweight is a major risk factor for the development of elevated blood pressure, and cardiovascular diseases. But it has net been known how obesity increases the risk of high blood pressure, making it difficult to develop evidence based therapies for obesity, hypertension and heart disease.
Do wealthier people receive too much medical care? In a Perspective article recently published in the New England Journal of Medicine, H. Gilbert Welch, MD, and Elliott Fisher, MD, of The Dartmouth Institute for Health Policy and Clinical Practice examine the association between income level and cancer diagnosis.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
› Verified 4 days ago
Nicole Mcaree, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Pillsbury St Ste 404, Concord, NH 03301 Phone: 603-228-7827 | |
Ms. Laura A Darling, M.S.CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Bridge St Ste 1a, Concord, NH 03301 Phone: 603-224-1551 Fax: 603-224-1330 | |
Christopher Paul Doherty, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 144 South St, Concord, NH 03301 Phone: 603-225-0862 | |
Patricia Morrell, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 152 South St, Concord, NH 03301 Phone: 603-225-0827 | |
Ms. Wanda Moulton Denoncour, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 Sewalls Falls Rd, Concord, NH 03301 Phone: 603-225-0853 | |
Mrs. Andrea Parker, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Fisherville Rd Unit 20, Concord, NH 03303 Phone: 603-410-7577 | |
Elizabeth Sirois, SLP-CFY/NH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 239 Pleasant St, Pleasant View Center, Concord, NH 03301 Phone: 603-224-6561 |